Board of Trustees of The Leland Stanford Junior University’s RenovoRx RNXT Stock Holding History
Bought
Maintained
Sold
Other funds holding RNXT
LBC
CG
TRCT
Board of Trustees of The Leland Stanford Junior University's RNXT Position: Q1 2022 in Review
Board of Trustees of The Leland Stanford Junior University sold out of RenovoRx (RNXT) in Q1 2022, closing a stake of 60,863 shares — an estimated $295K sold.
Board of Trustees of The Leland Stanford Junior University first reported a position in RNXT in Q3 2021 and held it in 2 quarters. The position peaked at $368K in Q3 2021. 12 funds tracked by Wall St. Rank hold RNXT as of Q1 2022.
- Board of Trustees of The Leland Stanford Junior University reported no remaining RenovoRx position as of Q1 2022 after selling out during the quarter.
- Board of Trustees of The Leland Stanford Junior University sold 60,863 RenovoRx shares in Q1 2022, an estimated $295K.
- Board of Trustees of The Leland Stanford Junior University first reported a position in RenovoRx in Q3 2021 and held it in 2 quarters.
- Board of Trustees of The Leland Stanford Junior University's RenovoRx position peaked at $368K in Q3 2021.
- 12 funds tracked by Wall St. Rank held RenovoRx as of Q1 2022.
Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q1 2022, filed 13 May 2022.